A study for of the infection status of Epstein-Barr virus in healthy young adults

Not Applicable

Recruiting

• Conditions: healthy young adults

• Registration Number: JPRN-UMIN000032099
• Lead Sponsor: Japan Agency for Medical Research and development

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-06-01
• Study Completion: 2022-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Not provided

Exclusion Criteria

Students, who are suffering from or have history of EBV-positive neoplasms, will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
We will measure the titers of anti-VCA-IgG and anti-EBNA antibodies in the peripheral blood (whole blood) from healthy donors. Then, we will measure EBV-DNA load of the peripheral blood from the EBV sero-positive donors and determine the cut-off value of the healthy people.

Secondary Outcome Measures

Name	Time	Method
We will identify the bacterial flora of nasal discharge and saliva from the EBV sero-positive donors.